#BiologicsSummit2021

6th Annual

WEDNESDAY, NOVEMBER 17, 2021

LIVE STREAM

Q&A AND POLLING

LIVE CHAT

#BiologicsSummit2021

EVENT AGENDA

11:30 A.M. ET

Welcome

Speaker:

Josie Cooper, Executive Director, Alliance for Patient Access

Session Info:

XXX

11:35 A.M. ET

Introduction

Speaker:

David Charles, MD, Founder, Alliance for Patient Access, Co-Convener, Biologics Prescribers Collaborative

Session Info:

XXX

11:40 A.M. ET

Innovation and Rare Disease

Speakers:

Richard White, Policy Analyst, National Organization for Rare Disorders

Layla Lohmann, DDS, Rare Disease Advocate

David Charles, MD, Founder, Alliance for Patient Access, Co-Convener, Biologics Prescribers Collaborative

Host: Josie Cooper, Executive Director, Alliance for Patient Access

Session Info:

XXX

12:00 P.M. ET

Advocate's Perspective: Color of Crohn's

Speakers:

Melodie Narain-Blackwell, Member, Color of Crohn's & Chronic Illness, Inc. Board of Directors

Host: Dennis Cryer, MD, Co-Convener, Biologics Prescribers Collaborative

Session Info:

XXX

12:12 P.M. ET

Keynote

Speakers:

Sarah Yim, MD, Director of the Office of Therapeutic Biologics and Biosimilars in FDA’s Center for Drug Evaluation and Research

Host: Gavin Clingham, JD, Policy Director, Alliance for Patient Access

Session Info:

XXX

12:40 P.M. ET

Break

Session Info:

XXX

12:46 P.M. ET

Policy Brief: A Federal and State Legislative Update

Speakers:

Brian Henderson, Director, State Government Affairs, Coalition of State Rheumatology Organizations

Angus Worthing, MD, Member, American College of Rheumatology Board of Directors

Host: Gavin Clingham, JD, Policy Director, Alliance for Patient Access

Session Info:

XXX

1:11 P.M. ET

Expanding Options: Biosimilars

Speakers:

Chad Pettit, Executive Director, Marketing, Amgen

Karen McKerihan, MSN, NP-C, Member, Rheumatology Nurses Society Board of Directors

Pam Traxel, Senior Vice President, American Cancer Society Cancer Action Network

Host: Susan Hepworth, Director of Media Affairs, Alliance for Patient Access

Session Info:

XXX

1:36 P.M. ET

Insulin Affordability and Interchangeables

Speakers:

Rob Goldsmith, Director, Policy and Advocacy, Endocrine Society

Host: Susan Hepworth, Director of Media Affairs, Alliance for Patient Access

Session Info:

XXX

1:53 P.M. ET

Closing Remarks

Speakers:

Rob Goldsmith, Endocrine Society

Host: Dennis Cryer, MD, Co-convener, Biologics Prescribers Collaborative

Session Info:

XXX

KEYNOTE SPEAKER

SARAH YIM, MD

DIRECTOR,
OFFICE OF THERAPEUTIC BIOLOGICS AND BIOSILMILARS IN FDA’S CENTER FOR DRUG EVALUATION AND RESEARCH

FEATURED SPEAKERS

DAVID CHARLES, MD

FOUNDER,
ALLIANCE FOR PATIENT ACCESS
CO-CONVENER,
BIOLOGICS PRESCRIBERS COLLABORATIVE

GAVIN CLINGHAM, JD

POLICY DIRECTOR,
ALLIANCE FOR PATIENT ACCESS

JOSIE COOPER

EXECUTIVE DIRECTOR,
ALLIANCE FOR PATIENT ACCESS

DENNIS CRYER, MD

CO-CONVENER,
BIOLOGICS PRESCRIBERS COLLABORATIVE

ROB GOLDSMITH

DIRECTOR, POLICY AND ADVOCACY,
ENDOCRINE SOCIETY

BRIAN HENDERSON

DIRECTOR,
STATE GOVERNMENT AFFAIRS,
COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS

SUSAN HEPWORTH

DIRECTOR OF MEDIA AFFAIRS
ALLIANCE FOR PATIENT ACCESS

LAYLA LOHMANN, DDS

RARE DISEASE ADVOCATE

KAREN MCKERIHAN,
MSN, NP-C

MEMBER,
RHEUMATOLOGY NURSES SOCIETY BOARD OF DIRECTORS

MELODIE NARAIN-BLACKWELL

MEMBER,
COLOR OF CROHN'S AND CHRONIC ILLNESS, INC. BOARD OF DIRECTORS

CHAD PETTIT

EXECUTIVE DIRECTOR,
MARKETING,
AMGEN

PAM TRAXEL

SENIOR VICE PRESIDENT,
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK

RICHARD WHITE

POLICY ANALYST,
NATIONAL ORGANIZATION OF RARE DISORDERS

ANGUS WORTHING, MD

MEMBER,
AMERICAN COLLEGE OF RHEUMATOLOGY BOARD OF DIRECTORS

ANGUS WORTHING, MD

MEMBER,
AMERICAN COLLEGE OF RHEUMATOLOGY BOARD OF DIRECTORS

CONVENED BY:

CO-HOSTED BY:

THANK YOU TO OUR SPONSORS: